Annual Cash & Cash Equivalents:
$269.50M+$73.60M(+37.57%)Summary
- As of today, SGRY annual cash & cash equivalents is $269.50 million, with the most recent change of +$73.60 million (+37.57%) on December 31, 2024.
- During the last 3 years, SGRY annual cash & cash equivalents has fallen by -$120.40 million (-30.88%).
- SGRY annual cash & cash equivalents is now -30.88% below its all-time high of $389.90 million, reached on December 31, 2021.
Performance
SGRY Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$250.10M+$20.80M(+9.07%)Summary
- As of today, SGRY quarterly cash & cash equivalents is $250.10 million, with the most recent change of +$20.80 million (+9.07%) on June 30, 2025.
- Over the past year, SGRY quarterly cash & cash equivalents has increased by +$36.60 million (+17.14%).
- SGRY quarterly cash & cash equivalents is now -53.85% below its all-time high of $541.90 million, reached on March 31, 2021.
Performance
SGRY Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SGRY Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +37.6% | +17.1% |
| 3Y3 Years | -30.9% | +10.0% |
| 5Y5 Years | +190.7% | -23.4% |
SGRY Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -30.9% | +37.6% | -11.6% | +61.6% |
| 5Y | 5-Year | -30.9% | +190.7% | -53.9% | +61.6% |
| All-Time | All-Time | -30.9% | >+9999.0% | -53.9% | +343.3% |
SGRY Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $250.10M(+9.1%) |
| Mar 2025 | - | $229.30M(-14.9%) |
| Dec 2024 | $269.50M(+37.6%) | $269.50M(+21.5%) |
| Sep 2024 | - | $221.80M(+3.9%) |
| Jun 2024 | - | $213.50M(+15.3%) |
| Mar 2024 | - | $185.20M(-5.5%) |
| Dec 2023 | $195.90M(-30.8%) | $195.90M(-17.0%) |
| Sep 2023 | - | $236.00M(+33.0%) |
| Jun 2023 | - | $177.40M(-27.7%) |
| Mar 2023 | - | $245.50M(-13.2%) |
| Dec 2022 | $282.90M(-27.4%) | $282.90M(+82.8%) |
| Sep 2022 | - | $154.80M(-31.9%) |
| Jun 2022 | - | $227.40M(-40.0%) |
| Mar 2022 | - | $378.90M(-2.8%) |
| Dec 2021 | $389.90M(+22.6%) | $389.90M(+18.0%) |
| Sep 2021 | - | $330.40M(-28.9%) |
| Jun 2021 | - | $464.80M(-14.2%) |
| Mar 2021 | - | $541.90M(+70.5%) |
| Dec 2020 | $317.90M(+242.9%) | $317.90M(-29.4%) |
| Sep 2020 | - | $450.00M(+37.9%) |
| Jun 2020 | - | $326.30M(+67.7%) |
| Mar 2020 | - | $194.60M(+109.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $92.70M(-49.7%) | $92.70M(-16.7%) |
| Sep 2019 | - | $111.30M(-5.2%) |
| Jun 2019 | - | $117.40M(-17.6%) |
| Mar 2019 | - | $142.50M(-22.7%) |
| Dec 2018 | $184.31M(+3.1%) | $184.31M(+132.9%) |
| Sep 2018 | - | $79.12M(-17.6%) |
| Jun 2018 | - | $96.07M(-14.8%) |
| Mar 2018 | - | $112.82M(-36.9%) |
| Dec 2017 | $178.72M(+121.8%) | $178.72M(-12.5%) |
| Sep 2017 | - | $204.27M(+214.2%) |
| Jun 2017 | - | $65.00M(-2.7%) |
| Mar 2017 | - | $66.84M(-17.0%) |
| Dec 2016 | $80.57M(+0.8%) | $80.57M(+24.9%) |
| Sep 2016 | - | $64.50M(+6.6%) |
| Jun 2016 | - | $60.50M(-59.4%) |
| Mar 2016 | - | $149.03M(+86.5%) |
| Dec 2015 | $79.92M(+6.7%) | $79.92M(+12.7%) |
| Sep 2015 | - | $70.90M(+14.4%) |
| Jun 2015 | - | $61.99M(+9.9%) |
| Mar 2015 | - | $56.42M(-24.7%) |
| Dec 2014 | $74.92M(+475.2%) | $74.92M |
| Dec 2013 | $13.03M(>+9900.0%) | - |
| Dec 2012 | $0.00 | - |
FAQ
- What is Surgery Partners, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Surgery Partners, Inc.?
- What is Surgery Partners, Inc. annual cash & cash equivalents year-on-year change?
- What is Surgery Partners, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Surgery Partners, Inc.?
- What is Surgery Partners, Inc. quarterly cash & cash equivalents year-on-year change?
What is Surgery Partners, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of SGRY is $269.50M
What is the all-time high annual cash & cash equivalents for Surgery Partners, Inc.?
Surgery Partners, Inc. all-time high annual cash & cash equivalents is $389.90M
What is Surgery Partners, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, SGRY annual cash & cash equivalents has changed by +$73.60M (+37.57%)
What is Surgery Partners, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SGRY is $250.10M
What is the all-time high quarterly cash & cash equivalents for Surgery Partners, Inc.?
Surgery Partners, Inc. all-time high quarterly cash & cash equivalents is $541.90M
What is Surgery Partners, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, SGRY quarterly cash & cash equivalents has changed by +$36.60M (+17.14%)